August 6, 2025 · Form 4 insider transaction
Harsanyi Zsolt bought 7,200 shares of Aptevo Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.; The RSUs vest in full on the first anniversary of the date of grant.